Masanobu Takahashi

8PUBLICATIONS
38CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jul 23, 2026
New Treatment Strategy and Future Research Direction for BRAF-Mutated Cancer.

|Apr 23, 2026
Inverse Relation Between Responses to Pembrolizumab Plus Chemotherapy and Subsequent Cetuximab Plus Paclitaxel in Head and Neck Cancer: Role of the Janus Kinase-Signal Transducer and Activator of Transcription Signaling Pathway.

|May 08, 2025
A multicenter, prospective, observational study of nivolumab readministration for advanced gastric cancer (NIVO RETURNS).

Hiroyuki Kodama, Yukiya Narita, Michio Nakamura

|Feb 28, 2025
Impact of genetic mutations on prognosis and chemotherapy efficacy in advanced appendiceal carcinoma: insights from the nationwide Japanese comprehensive genomic profiling test database.

Sakura Hiraide Taniguchi, Masanobu Takahashi, Shih-Wei Chiu

|Jan 17, 2025
Returning genetic risk information for hereditary cancers to participants in a population-based cohort study in Japan.

Kinuko Ohneda, Yoichi Suzuki, Yohei Hamanaka

|Aug 23, 2024
Tretinoin synergistically enhances the antitumor effect of combined BRAF, MEK, and EGFR inhibition in BRAFV600E colorectal cancer.

Yuya Yoshida, Masanobu Takahashi, Sakura Taniguchi

Pageof 2

Frequent Collaborators

3 joint publications

Chikashi Ishioka

1 joint publications

Morihito Okada

1 joint publications

Ken Kato

1 joint publications

Byoung Chul Cho